Prophylactic dopamine antagonist antiemetic medications vs placebo
Adverse events · adults receiving intravenous opioids
Prophylactic dopamine antagonist antiemetic medications showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
- Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting 2022 · Cochrane Headline outcomes onlyRR 2.34 [0.47, 11.61]3 studies · 527 participantsLow